Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06642610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

StatusCompleted
PhaseNot applicable
Started2025-06-15
View on ClinicalTrials.gov ↗

Amendment history

2026-09-18
Trial completed
Final enrollment: 14 participants (planned 70)
2025-07-27
Study Status v7
Completion date2026-07-30→2026-06-30
2025-06-25
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v6
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-11-30→2026-06-30
Completion date2025-11-30→2026-07-30
Start dateestimated 2025-03-15→confirmed 2025-06-15
Study sitesdetails revised at 1 of 1 site
2025-02-06
Study Identification, Study Status, Oversight, Contacts/Locations v5
Completion date2026-07-31→2025-11-30
Study sites0→1
2025-02-04
Study Status v4
Primary completion date2025-07-31→2025-11-30
Start date2025-01-15→2025-03-15
Show 3 earlier versions
2025-01-14
Study Status, Oversight, Study Description, Arms and Interventions, Outcome Measures, Eligibility v3
Start date2024-12-15→2025-01-15
Study arms3→2
Eligibility criteria+457 characters
[...] eady using CGM, we will just collect their personal CGM data, and they are not required to have OGTT or HbA1c visit. Exclusion Criteria: Pregnancy. History of transplant. Use of immunosuppressant drugs. Use of oral steroids or any medication known to interfere with glucose. Allergy to adhesives. Individuals with severe concurrent medical conditions that could confound glucose monitoring data (e.g., terminal illne [...]
2024-11-21
Study Status v2
Start date2024-10-30→2024-12-15
2024-10-22
Study Status, Oversight, Study Design, Arms and Interventions, Eligibility v1
PhaseNot specified→Not applicable
Completion date2025-08-01→2026-07-31
InterventionsNo intervention. (Other)→CGM Dynamic Index (CDI) (Device)
2024-10-11
Original filing
Indiana University
306 trials monitored
See 37 trials at risk
Diabetes
4,240 trials monitored
See 171 trials at risk
Cystic Fibrosis
285 trials monitored
See 14 trials at risk
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Trial Details
NCT Number NCT06642610
Lead Sponsor Indiana University
Conditions Prediabetes, Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
Enrollment 14 participants
Start Date 2025-06-15
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-17